Publication | Closed Access
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
586
Citations
37
References
2017
Year
Ritux 3PharmacologyPharmacotherapyMedicineFirst-line Rituximab
| Year | Citations | |
|---|---|---|
Page 1
Page 1